Related Experiment Video
Updated: Jul 22, 2026

Reliable Method for Assessing Seed Germination, Dormancy, and Mortality under Field Conditions
Published on: November 6, 2016
ADMA and NT pro-BNP are associated with overall mortality in elderly
Safoura Sheikh Rezaei1, Stefan Weisshaar1, Brigitte Litschauer1
1Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
Insights
Asymmetrical dimethylarginine (ADMA) and NT pro-BNP are early mortality risk markers in geriatric patients. Increased levels of these markers, along with male sex and older age, predict mortality in this population.
Area of Science:
- Geriatric Medicine
- Cardiovascular Disease Research
- Biomarker Discovery
Background:
- Elevated asymmetrical dimethylarginine (ADMA) and NT pro-BNP are linked to mortality in cardiovascular disease and general populations.
- Prognostic value of these markers in older adults remains under-investigated.
- Geriatric care patients represent a unique population for assessing mortality risk factors.
Purpose of the Study:
- To evaluate the prognostic significance of various factors, including laboratory markers, in predicting mortality among geriatric care patients.
- To establish the role of ADMA and NT pro-BNP as mortality predictors in an elderly cohort.
- To identify key clinical and demographic predictors of survival in long-term geriatric care.
Main Methods:
- Prospective observational single-center cohort study.
- Collection of blood samples for ADMA, NT pro-BNP, SDMA, L-arginine, and CRP.
- Mortality follow-up up to 90 months, analyzed using Spearman correlation and Cox proportional hazard models.
Main Results:
- Analysis included 449 geriatric care patients, with 381 deaths during follow-up.
- Significant mortality predictors identified: male sex, older age, lower BMI, neuroleptic medication use, peripheral artery disease, and elevated ADMA, NT pro-BNP, and CRP.
- Cox regression analysis confirmed these factors as significant predictors.
Conclusions:
- Asymmetrical dimethylarginine (ADMA) and NT pro-BNP concentrations serve as early risk markers for overall mortality in geriatric care settings.
- Use of neuroleptic medication is associated with increased mortality risk in this elderly population.
- These findings support the utility of specific biomarkers and clinical factors for risk stratification in geriatric patients.
Background:
Increased asymmetrical dimethylarginine (ADMA) and NT pro-BNP concentrations have been associated with mortality in patients with cardiovascular (CV) disease and the general population. The use of these prognostic markers in an older population is not established yet. The aim of the present study was to investigate the prognostic value of age, sex, BMI, co-medication and CV laboratory risk markers in geriatric care patients.
Materials And Methods:
In this prospective observational single-centre cohort study data of long-term geriatric care patients were collected. Blood samples were collected between 14.09.2009 and 16.12.2009, and mortality was recorded up to 90 months. ADMA, its symmetric isomer SDMA, L-arginine, NT pro-BNP and CRP were determined at study entry. Simple associations of risk factors for survival period were explored by Spearman correlation coefficient. Significant univariate predictors for survival period were used in the Cox proportional hazard model.
Results:
A total of 481 patients were screened, and data from 449 patients were analysed. A total of 381 patients died during the observation period. Full data sets from 344 patients were used for Cox regression analysis. Male sex, older age, lower BMI, use of neuroleptic medicine, peripheral artery disease, and elevated plasma concentrations of ADMA, NT pro-BNP, and CRP were significant predictors of mortality.
Conclusion:
The concentration of ADMA and NT pro-BNP may be used as an early risk marker for overall mortality in geriatric care. Neuroleptic medicine is associated with increased mortality in this population.
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacodynamics in Geriatric Patients: Effects of Age
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

